Author Information
StephenJones has 4 Published Articles

United States of America,
SAN DIEGO,
CA,
Imgen Corporation,
Flintkote Avenue



Polyclonal Antibody to FBXO9/F-box protein 9

Posted On : May-13-2011 | seen (367) times | Article Word Count : 481 |

Researchers have indicated that they want access to novel target antibodies quickly to aid in their research. IMGENEX is therefore pleased to be able to offer researchers access to products
Researchers have indicated that they want access to novel target antibodies quickly to aid in their research. IMGENEX is therefore pleased to be able to offer researchers access to products that are not fully characterized or validated. IMGENEX IMX antibodies are shown by Peptide ELISA to bind to the peptide used as immunogen. Investigators should empirically determine the suitability of the antibody, including optimal dilutions, for other applications of interest.
We cannot guarantee that the IMX antibody will work in any application other than in a Peptide ELISA against the peptide used as immunogen and therefore can not offer a refund if the antibody does not work in your application.
IMX antibodies are offered at a lower price compared to more highly validated antibodies.
We are not able to provide the peptide used as immunogen for IMX antibodies.
As IMX antibodies are not fully validated we appreciate your feedback. Customer feedback is used to help generate testing methodologies which can lead to further product validation or withdrawal.

F-box only protein 9 is a Ubl conjugation pathway protein and it contains one F-box domain and one TPR repeat. FBXO9 may act as a potential sepsis biomarker or therapeutic target. The F-box proteins constitute one of the four subunits of the ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which functions in phosphorylation-dependent ubiquitination.
Antigen
Amino acids 8-25 CHSDADRVGDEGNESPAE of mouse FBXO9 protein were used as the immunogen. Researchers have indicated that they want access to novel target antibodies quickly to aid in their research. IMGENEX is therefore pleased to be able to offer researchers access to products that are not fully characterized or validated. IMGENEX IMX antibodies are shown by Peptide ELISA to bind to the peptide used as immunogen. Investigators should empirically determine the suitability of the antibody, including optimal dilutions, for other applications of interest.
We cannot guarantee that the IMX antibody will work in any application other than in a Peptide ELISA against the peptide used as immunogen and therefore can not offer a refund if the antibody does not work in your application.
IMX antibodies are offered at a lower price compared to more highly validated antibodies.
We are not able to provide the peptide used as immunogen for IMX antibodies.
As IMX antibodies are not fully validated we appreciate your feedback. Customer feedback is used to help generate testing methodologies which can lead to further product validation or withdrawal.

F-box only protein 9 is a Ubl conjugation pathway protein and it contains one F-box domain and one TPR repeat. FBXO9 may act as a potential sepsis biomarker or therapeutic target. The F-box proteins constitute one of the four subunits of the ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which functions in phosphorylation-dependent ubiquitination.
Antigen
Amino acids 8-25 CHSDADRVGDEGNESPAE of mouse FBXO9 protein were used as the immunogen.

Article Source : http://www.articleseen.com/Article_Polyclonal Antibody to FBXO9/F-box protein 9_62082.aspx

Author Resource :
IMGENEX India Pvt Ltd. the only biotech company in Orissa and one of its kinds in Eastern India. IMGENEX India started in Oct as an outsourcing branch of IMGENEX Corporation, San Diego, USA. Find out more information about ELISA Confirmed.

Keywords : ELISA Confirmed,

Category : Health and Fitness : Alternative Medicine

Bookmark and Share Print this Article Send to Friend